|Articles|October 30, 2019
HCP Monitoring in Downstream Process Samples
Author(s)PharmaFluidics
μPAC™ technology has been used for analysing HCP impurities originating from recombinant expression systems used in the production of mAb based biotherapeutics.
Trending on LCGC International
1
HPLC, PTR-ToF-MS Enable AI Grading of White Tea
2
Analytical Procedure Lifecycle Approaches in Accordance With ICH Q14 and ICH Q2(R2): Opportunity Knocks or Just Another Challenge and Headache? (Part 2)
3
LC-MS/MS Links Vitamin D Levels to Sleep Timing
4
Highlights from the HPLC2026 Conference through the Lens of LC Troubleshooting
5